Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dual-Hormone Closed-Loop Glucose Control in Type 1 Diabetes
2019-001631-31Phase 4Completed
- Sponsor
- Steno Diabetes Center Copenhagen
- Start
- Apr 2019
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 4, randomised trial of glucagon and human insulin in diabetes mellitus type 1 (T1D) (2 arms), sponsored by Steno Diabetes Center Copenhagen. Primary endpoint: Percentage of time with glucose values < 3.9 mmol/l. Started Apr 2019; status: completed.
02
Drugs
glucagonhuman insulin
03
Conditions
diabetes mellitus type 1 (T1D)
Beyond the preview
Go deeper on 2019-001631-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-001631-31.